Processing human lymph node samples for single-cell assays

Tobias Roider1,2,3, Berit J Brinkmann1,2,3,4, Sascha Dietrich1,2,3

  • 1European Molecular Biology Laboratory (EMBL), 69120 Heidelberg, Germany.

STAR Protocols
|November 8, 2021
PubMed

Insights

This study presents a gentle, time-efficient protocol for processing human lymph node samples. The method yields single-cell suspensions for advanced analyses like single-cell RNA sequencing in lymphoma research.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Non-Hodgkin's lymphoma (NHL) predominantly resides within lymph nodes, shielded by the tumor microenvironment.
  • Understanding cellular heterogeneity and cell interactions in NHL requires patient-derived samples.
  • Delicate assays necessitate high-quality single-cell suspensions from lymph node tissue.

Purpose of the Study:

  • To develop a rapid and gentle protocol for processing human lymph node samples.
  • To generate single-cell suspensions suitable for sensitive downstream applications.
  • To facilitate the study of cellular heterogeneity and cell-cell interactions in lymphoma.

Main Methods:

  • A novel protocol for human lymph node sample processing is described.
  • The method avoids enzymatic digestion and mechanical stress.
  • Optimization focused on preserving cellular integrity for single-cell analysis.

Main Results:

  • The protocol is time-efficient and gentle on delicate cells.
  • It successfully produces single-cell suspensions from lymph node tissue.
  • The resulting suspensions are suitable for assays like single-cell RNA sequencing.

Conclusions:

  • This protocol offers an effective means to prepare patient-derived lymph node samples.
  • It supports advanced single-cell analyses crucial for lymphoma research.
  • The method aids in investigating the tumor microenvironment and cellular heterogeneity in NHL.

Related Concept Videos